ArticleThe Lancet. Infectious diseases2024
Novel strain of multidrug non-susceptible Neisseria gonorrhoeae in the USA.
Abstract readLetter
In one paragraph
Article in The Lancet. Infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Rapid expansion of penA allele 60.001-containing endemic ceftriaxone-resistant gonococcal ST8123 lineage in Hangzhou, China.Infection · 2026Article
- Deep learning-enabled discovery of antibiotics effective againstScience translational medicine · 2026Article
- Inferring Sexual Network Bridging Using Genomics: A Simulation Study.medRxiv : the preprint server for health sciences · 2026Article
- A penicillin-binding protein inhibitor series to target drug-resistant Neisseria gonorrhoeae.Nature microbiology · 2026Article
- A rapid molecular test for gonorrhea and chlamydia compared to Gram stain for symptomatic patients in a specialized STI clinic: a randomized controlled trial.Sexually transmitted diseases · 2026Article
- Stepwise evolution and clonal enrichment of gepotidacin resistance inAntimicrobial agents and chemotherapy · 2026Article
- Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Article
- Clonal Expansion ofInfection and drug resistance · 2026Article
- Pre-clinical efficacy of a C4BP hexameric IgG Fc fusion protein against Neisseria gonorrhoeae.PloS one · 2026Article
- Estimating the undetected burden and the likelihood of strain persistence of drug-resistant Neisseria gonorrhoeae.American journal of epidemiology · 2025Article
- High Prevalence of Ceftriaxone-Resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023-2024.The Journal of infectious diseases · 2025Article
- Routine Pharyngeal Gonorrhea Test of Cure: Is It an Effective Cephalosporin-Resistant Gonorrhea Control Strategy?Sexually transmitted diseases · 2025Article
- Antimicrobial Resistance in Curable Sexually Transmitted Infections.Current HIV/AIDS reports · 2025Review
- A new class of penicillin-binding protein inhibitors to address drug-resistantbioRxiv : the preprint server for biology · 2024Article
- Neisseria gonorrhoeae treatment failure to the recommended antibiotic regimen-Québec, Canada, 2015-19.The Journal of antimicrobial chemotherapy · 2024Observational
- Emergence of Extensively Drug-Resistant Neisseria gonorrhoeae, France, 2023.Emerging infectious diseases · 2024Article
- Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Viet Nam.The Lancet. Infectious diseases · 2024Article
- Two New Strains of Drug-resistant Neisseria gonorrhoeae in a Bisexual Man having Sex with Men in Wroclaw, Poland.Acta dermato-venereologica · 2024Article
- Emergence and evolution of mosaicFrontiers in microbiology · 2024Article
- The Role of Emergency and Primary Care in Combating the Rise of Gonorrhea: Another Purview Paradox?Journal of primary care & community healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Jennifer L ReimcheDivision of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA. Electronic address: nkv3@cdc.gov.
Cau D PhamDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
Sandeep J JosephDivision of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
Shelby HuttonDivision of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
John C CarteeDivision of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
Yuheng RuanSouth Cove Community Health Center, Boston, MA, USA.
Mandy BreauxSouth Cove Community Health Center, Boston, MA, USA.
Caryn IvanofMassachusetts Department of Public Health, Bureau of Infectious Diseases and Laboratory Sciences, Boston, MA, USA.
Akita JoshiMassachusetts Department of Public Health, Bureau of Infectious Diseases and Laboratory Sciences, Boston, MA, USA.
Mary DeMartinoMassachusetts Department of Public Health, Bureau of Infectious Diseases and Laboratory Sciences, Boston, MA, USA.
James E KirbyDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Lindley A BarbeeDivision of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
Ellen N KershDivision of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
Kathleen A RooseveltMassachusetts Department of Public Health, Bureau of Infectious Diseases and Laboratory Sciences, Boston, MA, USA.
Katherine K HsuMassachusetts Department of Public Health, Bureau of Infectious Diseases and Laboratory Sciences, Boston, MA, USA.
Funding
Intramural CDC HHS CC999999NCEZID CDC HHS NU50CK000518
Abstract
PubMed holds no abstract for this paper.
Indexed as
GonorrheaNeisseria gonorrhoeaeAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsAnti-Bacterial Agents
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.